Canada
SynerGenetics Bioscience Inc. is a Canadian plant genetics research and development company focusing on creating high-yield CBD hemp strains and seeds. With a management team boasting over 35 years of combined experience in the cannabis and hemp industry, the company is poised to capitalize on the burgeoning hemp and CBD markets.
Utilizing proprietary technology, SG’s R&D team has successfully identified desirable plant traits to develop hemp strains yielding 12% or more CBD content, addressing significant challenges in commercial hemp farming. This stands in stark contrast to the industry average of less than 7% CBD content, marking a significant financial and qualitative advantage.
Founded in 2019 and with headquarters in Canada, the company recently secured a $6.00 million Seed Round investment on 20th March 2020.
With no specific information on the source of the recent investment, the company’s innovative approach within the biotechnology sector and its leadership's deep industry knowledge positions SynerGenetics Bioscience Inc. as a compelling player in the burgeoning CBD and hemp marketplace.
